-
EP3209277
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3209277
| EP3209277 - USE OF ISOSORBIDE ESTER AND N-ACYLATED AMINO ACID DERIVATIVES AS ANTI-AGEING AGENT FOR THE HUMAN SKIN [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 28.12.2017 Database last updated on 06.11.2024 | |
| Former | Request for examination was made Status updated on 28.07.2017 | ||
| Former | The international publication has been made Status updated on 17.03.2017 | Most recent event Tooltip | 28.12.2017 | Withdrawal of application | published on 24.01.2018 [2018/04] | Applicant(s) | For all designated states Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC 75 Quai d'Orsay 75321 Paris Cedex 7 / FR | [2017/35] | Inventor(s) | 01 /
CATTUZZATO, Laetitia 5 Rue des Maçons F-81100 Castres / FR | 02 /
DUMONT, Sandy 11 Rue des Falaises F-81200 Caucalieres / FR | 03 /
GUILBOT, Jerôme 79 Rue du Gazel F-81100 Castres / FR | [2017/35] | Representative(s) | Conan, Philippe Claude L'Air Liquide SA Direction de la Propriété Intellectuelle 75, quai d'Orsay 75321 Paris Cedex 07 / FR | [2017/35] | Application number, filing date | 15797121.9 | 16.10.2015 | [2017/35] | WO2015FR52791 | Priority number, date | FR20140060254 | 24.10.2014 Original published format: FR 1460254 | [2017/35] | Filing language | FR | Procedural language | FR | Publication | Type: | A1 Application with search report | No.: | WO2016062948 | Date: | 28.04.2016 | Language: | FR | [2016/17] | Type: | A1 Application with search report | No.: | EP3209277 | Date: | 30.08.2017 | Language: | FR | The application published by WIPO in one of the EPO official languages on 28.04.2016 takes the place of the publication of the European patent application. | [2017/35] | Search report(s) | International search report - published on: | EP | 28.04.2016 | Classification | IPC: | A61K8/49, A61K31/34, A61K31/4025, A61P17/00, A61Q19/08 | [2017/35] | CPC: |
A61K8/4973 (EP,CN,KR,US);
A61K31/34 (EP,CN,KR,US);
A61K31/4025 (EP,CN,KR,US);
A61K8/42 (CN);
A61P17/00 (EP);
A61Q19/08 (EP,CN,KR,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/35] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | Title | German: | VERWENDUNG VON ISOSORBIDESTER UND N-ACYLIERTEN AMINOSÄUREDERIVATEN ALS ALTERUNGSSCHUTZMITTEL FÜR DIE MENSCHLICHE HAUT | [2017/35] | English: | USE OF ISOSORBIDE ESTER AND N-ACYLATED AMINO ACID DERIVATIVES AS ANTI-AGEING AGENT FOR THE HUMAN SKIN | [2017/35] | French: | Utilisation d'ester d'isosorbide et de dérivés N-acylés d'acides aminés comme agent antivieillissement de la peau humaine | [2017/35] | Entry into regional phase | 24.05.2017 | National basic fee paid | 24.05.2017 | Designation fee(s) paid | 24.05.2017 | Examination fee paid | Examination procedure | 16.03.2017 | Date on which the examining division has become responsible | 24.05.2017 | Examination requested [2017/35] | 15.12.2017 | Application withdrawn by applicant [2018/04] | Fees paid | Renewal fee | 25.10.2017 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XY]WO2013001192 (SEPPIC SA [FR], et al) [X] 1-4 * claim - * * page 3, lines 5-12 * * page 5, lines 26-34 * * page 15, line 30 - page 16, line 27 * * page 17, lines 3-12 * * example - * [Y] 1-4; | [Y]WO2011059866 (SYTHEON LTD [US]) [Y] 1-4 * page 1, première phrase du paragraphe [0001] * * claims 14-23 * * example - *; | [Y]US2013183257 (CHAUDHURI RATAN K [US]) [Y] 1-4 * claim - * * page 1, paragraph 2 *; | [Y]EP1891929 (KAO CORP [JP]) [Y] 1-4 * claims 1-2 *; | [A]WO2013006760 (PROCTER & GAMBLE [US], et al) [A] 1-4 * claim - * | by applicant | WO2010127396 | WO2010056908 | FR2783169 | WO9717835 | US6864250 | EP0505868 | JP2002179518 | EP1471881 | JP2000229121 | WO2010034917 | WO2013001192 | WO9600719 | - SCHULZE ET AL., "Stiffening of human skin fibroblasts with age", CLIN. PLAST. SURG., (2012), vol. 39, no. 1, pages 9 - 20 | - BARAIBAR; FRIGUET, "Oxidative proteome modifications target specific cellular pathways during oxidative stress, cellular senescence and ageing", EXP GERONTOL, (2013), vol. 48, no. 7, pages 620 - 5 | - KONDO ET AL., "Inhibitory effects of human serum on human fetal skin fibroblast migration: migration-inhibitory activity and substances in serum, and its age-related changes", IN VITRO CELL DEV BIOL ANIM, (2000), vol. 36, no. 4, pages 256 - 61 | - JANG ET AL., "Prolonged activation of ERK contributes to the photorejuvenation effect in photodynamis therapy in human dermal fibroblasts", JID, (2013), vol. 133, no. 9, pages 2265 - 75 | - HOURELD; ABRAHAMSE, "Low-intensity laser irradiation stimulates wound healing in diabetic wounded fibroblast cells (WS1", DIABETES TECHNOL THER, (201012), vol. 12, no. 12 | - TANG ET AL., "A rice-derived recombinant human lactoferrin stimulates fibroblast proliferation, migration, and sustains cell survival", WOUND REPAIR REGEN, (201001), vol. 18, no. 1 | - ROJO ET AL., "Wound healing properties of nut oil from Pouteria lucuma", J COSMET DERMATOL, (20100909), vol. 9, no. 3 | - KARLESKIND A., Manuel des corps gras, LAVOISIER, (1992), vol. 1, 2, pages 65 - 78,115-2 |